You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
|
|---|---|
| Published in |
New England Journal of Medicine, August 2012
|
| DOI | 10.1056/nejmoa1112072 |
| Pubmed ID | |
| Authors |
Ronald F van Vollenhoven, Roy Fleischmann, Stanley Cohen, Eun Bong Lee, Juan A García Meijide, Sylke Wagner, Sarka Forejtova, Samuel H Zwillich, David Gruben, Tamas Koncz, Gene V Wallenstein, Sriram Krishnaswami, John D Bradley, Bethanie Wilkinson |
X Demographics
The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 13% |
| Spain | 4 | 9% |
| France | 3 | 7% |
| United Kingdom | 2 | 4% |
| Japan | 1 | 2% |
| Colombia | 1 | 2% |
| Canada | 1 | 2% |
| Brazil | 1 | 2% |
| Uruguay | 1 | 2% |
| Other | 5 | 11% |
| Unknown | 21 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 34 | 74% |
| Practitioners (doctors, other healthcare professionals) | 6 | 13% |
| Scientists | 5 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 608 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 3 | <1% |
| United States | 2 | <1% |
| United Kingdom | 2 | <1% |
| Japan | 2 | <1% |
| India | 1 | <1% |
| Canada | 1 | <1% |
| Argentina | 1 | <1% |
| Australia | 1 | <1% |
| Singapore | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 593 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 90 | 15% |
| Other | 71 | 12% |
| Student > Master | 67 | 11% |
| Student > Ph. D. Student | 66 | 11% |
| Student > Bachelor | 45 | 7% |
| Other | 127 | 21% |
| Unknown | 142 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 241 | 40% |
| Agricultural and Biological Sciences | 48 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 40 | 7% |
| Biochemistry, Genetics and Molecular Biology | 26 | 4% |
| Immunology and Microbiology | 21 | 3% |
| Other | 71 | 12% |
| Unknown | 161 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 64. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 June 2023.
All research outputs
#683,734
of 26,017,215 outputs
Outputs from New England Journal of Medicine
#7,833
of 32,765 outputs
Outputs of similar age
#3,495
of 189,809 outputs
Outputs of similar age from New England Journal of Medicine
#93
of 328 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,809 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 328 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.